Evidence map›Paper›PMID 29942488›Full record

ArticleClinical and translational allergy2018

Tonsillar cytokine expression between patients with tonsillar hypertrophy and recurrent tonsillitis.

Emilia Mikola, Varpu Elenius, Maria Saarinen, Oscar Palomares, Matti Waris, Riitta Turunen, Tuomo Puhakka, Lotta Ivaska, Beate Rückert, Alar Aab and 7 more

Open access · goldAbstract read
In one paragraph

Article in Clinical and translational allergy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 25 citations in OpenAlex.

  1. Deciphering the Inflammatory Network in Pediatric Recurrent Tonsillitis: The Role of TRAF6, IRAK1, and miR-146a-5p.Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. What Does the Microbiome in the Tonsil Tell Us?Clinical and experimental otorhinolaryngology · 2021
    Article
  8. Article
  9. COVID-19 in the tonsillectomised population.Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale · 2021
    Observational
  10. Article
  11. Article
  12. Article
  13. Narrow Band Imaging for lingual tonsil hypertrophy and inflammation, in laryngo-pharyngeal reflux disease.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2020
    Observational
  14. Rhinovirus species and tonsillar immune responses.Clinical and translational allergy · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 7 institutions in 5 countries.

Emilia Mikola1Department of Otorhinolaryngology, Turku University Hospital and Turku University, Turku, Finland.
Varpu Elenius *2Department of Paediatrics and Adolescent Medicine, Turku University Hospital and Turku University, P.O. Box 52, 20520 Turku, Finland.
Maria Saarinen *2Department of Paediatrics and Adolescent Medicine, Turku University Hospital and Turku University, P.O. Box 52, 20520 Turku, Finland.
Oscar Palomares3Swiss Institute of Allergy and Asthma Research, University of Zürich, Davos, Switzerland.
Matti Waris6Department of Clinical Virology, Turku University Hospital, Turku, Finland.
Riitta Turunen2Department of Paediatrics and Adolescent Medicine, Turku University Hospital and Turku University, P.O. Box 52, 20520 Turku, Finland.
Tuomo Puhakka1Department of Otorhinolaryngology, Turku University Hospital and Turku University, Turku, Finland.
Lotta Ivaska1Department of Otorhinolaryngology, Turku University Hospital and Turku University, Turku, Finland.
Beate Rückert3Swiss Institute of Allergy and Asthma Research, University of Zürich, Davos, Switzerland.
Alar Aab3Swiss Institute of Allergy and Asthma Research, University of Zürich, Davos, Switzerland.
Tero Vahlberg9Department of Biostatistics, University of Turku and Turku University Hospital, Turku, Finland.
Tytti Vuorinen6Department of Clinical Virology, Turku University Hospital, Turku, Finland.
Tobias Allander10Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden.
Carlos A Camargo11Department of Emergency Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, USA.
Mübeccel Akdis3Swiss Institute of Allergy and Asthma Research, University of Zürich, Davos, Switzerland.
Cezmi A Akdis3Swiss Institute of Allergy and Asthma Research, University of Zürich, Davos, Switzerland.
Tuomas Jartti2Department of Paediatrics and Adolescent Medicine, Turku University Hospital and Turku University, P.O. Box 52, 20520 Turku, Finland.ORCID 0000-0003-2748-5362
Turku University Hospital · FIUniversity of Turku · FICK-CARE · CHUniversity of Zurich · CHHarvard University · USKarolinska University Hospital · SEUniversidad Complutense de Madrid · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTonsils provide an innovative in vivo model for investigating immune response to infections and allergens. However, data are scarce on the differences in tonsillar virus infections and immune responses between patients with tonsillar hypertrophy or recurrent tonsillitis. We investigated the differences in virus detection and T cell and interferon gene expression in patients undergoing tonsillectomy due to tonsillar hypertrophy or recurrent tonsillitis.

methodsTonsils of 89 surgical patients with tonsillar hypertrophy (n = 47) or recurrent tonsillitis (n = 42) were analysed. Patients were carefully characterized clinically. Standard questionnaire was used to asses preceding and allergy symptoms. Respiratory viruses were analysed in tonsils and nasopharynx by PCR. Quantitative real-time PCR was used to analyse intratonsillar gene expressions of IFN-α, IFN-β, IFN-γ, IL-10, IL-13, IL-17, IL-28, IL-29, IL-37, TGF-β, FOXP3, GATA3, RORC2 and Tbet.

resultsMedian age of the subjects was 15 years (range 2-60). Patients with tonsillar hypertrophy were younger, smoked less often, had less pollen allergy and had more adenovirus, bocavirus-1, coronavirus and rhinovirus in nasopharynx (all

conclusionsIntratonsillar T cell and interferon gene expressions appeared to be relatively stable for both tonsillar hypertrophy and recurrent tonsillitis. Of the studied cytokines, only newly discovered anti-inflammatory cytokine IL-37, was independently associated with tonsillar hypertrophy showing slightly stronger anti-inflammatory response in these patients.

Indexed as

AllergyAsthmaChildCytokineInterferonInterleukinT helper cellTonsilVirus

Identifiers

PMID29942488
PMCPMC5963068
OpenAlexW2804276751

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.